COMPANY PROFILE

Warp Drive Bio

Develops genomic search engine and customized search queries that reveal hidden natural products based on genomic signature

Cambridge, United StatesFounded 2011Biotech & Life Sciences

Valuation $238M Market cap · 2020

At a glance

Status: Listed
Founded: 2011
Headquarters: Cambridge, United States
Listing: IPO 2018
Open positions: None listed
Dealroom signal: 0.0/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, DNA, Genetics and genomics, AI Drug Discovery, Techbio, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b

Founder mafia, market maps, research and news connected to this company by Dealroom

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
POST IPO EQUITYOther financing	Jul 2022	$265M	—	Undisclosed	↗
POST IPO EQUITYOther financing	Feb 2021	$261M	—	Undisclosed	—

Warp Drive Bio website traffic

Latest recorded traffic for Warp Drive Bio is 6.1K monthly website visits, down 23.8% over the last three months.

Latest monthly visits6.1K 3-month web change-23.8%

Monthly website visitsApr 2016–Jan 2023

Summary metrics are public; monthly history is available with a demoCompare with peers →

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
NTNucleome TherapeuticsDecoding the dark matter of the human genome to discover first-in-class precision medicine	Oxford, United Kingdom	Operational	53	$47M	$160M
OPOppilotechComputational biology platform for first-in-class drug discovery	London, United Kingdom	Operational
FGFios GenomicsProvider of an extensive range of data analysis and integration services	Edinburgh, United Kingdom	Operational
CDC4X DiscoveryC4X Discovery - building the world's most productive drug discovery engine	Manchester, United Kingdom	Operational
SOSoluPreventing epidemics with genomics	Helsinki, Finland	Operational
DSDeep Trait S.A.Biotechnology company with a mission to address fundamental questions of food supply, health care and life itself with artificial intelligence	Aschersleben, Germany	Operational
WGWhitelab GenomicsAI platform for accelerating genomic medicine development	Évry-Courcouronnes, France	Operational
MIMicrobioticaMicrobiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers	Little Chesterford, United Kingdom	Operational